Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
M1 Kliniken Temettü
Temettü kriter kontrolleri 3/6
M1 Kliniken is a dividend paying company with a current yield of 2.97% that is well covered by earnings.
Anahtar bilgiler
3.0%
Temettü verimi
55%
Ödeme oranı
| Sektör ortalama getirisi | 3.0% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | €0.500 |
| Hisse başına kazanç | €0.90 |
| Temettü verim tahmini | 4.7% |
Son temettü güncellemeleri
Recent updates
Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%
Sep 24
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: M12 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: M12's dividend payments have increased, but the company has only paid a dividend for 8 years.
Piyasaya Karşı Temettü Getirisi
| M1 Kliniken Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (M12) | 3.0% |
| Pazarın Alt %25'i (DE) | 1.6% |
| Pazarın En İyi %25'i (DE) | 4.8% |
| Sektör Ortalaması (Healthcare) | 3.0% |
| Analist tahmini (M12) (3 yıla kadar) | 4.7% |
Önemli Temettü: M12's dividend (2.97%) is higher than the bottom 25% of dividend payers in the German market (1.56%).
Yüksek Temettü: M12's dividend (2.97%) is low compared to the top 25% of dividend payers in the German market (4.73%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonable payout ratio (54.9%), M12's dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (49.6%), M12's dividend payments are well covered by cash flows.